Despite ovarian cancer’s high proportion of HRD tumors with suspected high TMB, increased infiltration by CD8+ TILs, and high expression of tumor antigens capable of eliciting spontaneous anti-tumor responses, initial attempts at immunotherapy in ovarian cancer were largely underwhelming [47,48,73,104]. This evidence concerns the gene CD8A and neoplasm.